While many future biomarker investigations for schizophrenia and psychosis may still largely be hypothesis-free, the growing literature and relative consistency in the data implicating genes such as NRG1 and the glutamatergic system as a whole are providing researchers within neuropsychiatric genetics with more mechanistic correlates of these biomarkers. The gene discussed is NRG1; the disease is schizophrenia.